摘要
本指南是自 1982年以来的第三个版本 ,由来自非洲、亚洲、拉丁美洲、欧洲、美国和CIOMS秘书处的 10名专家共同商议起草 ,由 2 1条指导原则及其注释组成。与 1982年和 1993年的两个版本一样 ,2 0 0 2版指南旨在规范各国的人体生物医学研究政策 ,根据各地情况应用伦理标准 ,以及确立和完善伦理审查机制。
This is the third version in the series of biomedical-research ethical guidelines issued by CIOMS since 1982. The members of redrafting group come from Africa, Asia, Latin America, Europe and Latin America, the United States and the CIOMS secretariat. Its core consists of 21 guidelines with commentaries. Like those of 1982 and 1993, the 2002 CIOMS guidelines are designed to be of use to countries in defining national policies on the ethics of biomedical research involving human subjects, applying ethical standards in local circumstances, and establishing or improving ethical review mechanisms.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2003年第1期107-110,共4页
Chinese Journal of Clinical Pharmacology and Therapeutics
关键词
医学伦理学
临床试验
国际医学科学组织
指南
medical ethics
clinical trial
Council for International Organizations of Medical Sciences
guidelines